Age-related changes in the cerebrospinal fluid level of β-endorphin and substance P

Journal of Neural Transmission

Volumn 105, Issue 1, 1998, Pages 53-58

  Nagamitsu, S ^a   Matsuishi, T ^a   Komori, H ^a   Yamashita, Y ^a   Eguchi, H ^a   Ichikawa, K ^b   Fujimoto, T ^c   Kato, H ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITAKYUSHU CITY YAHATA HOSPITAL   (Japan)

^c Fujimoto Children's Hospital   (Japan)

Author keywords

endorphin; Age; Cerebrospinal fluid; Substance P

Indexed keywords

BETA ENDORPHIN; NEUROPEPTIDE; SUBSTANCE P;

ADULT; AGE; ARTICLE; CEREBROSPINAL FLUID LEVEL; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; INFANT; MALE; NORMAL HUMAN; NORMAL VALUE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; BETA-ENDORPHIN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; REFERENCE VALUES; SUBSTANCE P;

EID: 0031952573     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050037     Document Type: Article

References (20)

1. Bach FW, Schmidt JF, Faber T (1992) Radioimmunoassay of β-endorphin in ventricular and lumbar cerebrospinal fluid. Clin Chem 38: 847-852
2. Charlton CG, Heike CJ (1986) Ontogeny of substance P receptors in rat spinal cord: quantitative changes in receptor number and differential expression in specific loci. Brain Res 394: 81-91
3. Cooper PE, Fernstrom MH, Rostad OP, Leeman SE, Martin JB (1981) The regional distribution of somatostain, substance P and neurotensin in human brain. Brain Res 218: 219-312
4. Crisp T, Stafinsky JL, Hoskins DL, Perni VC, Uram M, Gordon TL (1994) Age-related changes in the spinal antinociceptive effects of DAGO, DPDPE and β-endorphin in the rat. Brain Res 643: 282-286
5. Echenne B, Bressot N, Bassir M, Daures JP, Rabinowitz A (1991) Cerebrospinal fluid β-endorphin and cortisol study in Rett syndrome. J Child Neurol 6: 257-262
6. Frederickson RC, Geary LE (1982) Endogeneous opioid peptides: review of physiological, pharmacological and clinical aspects. Prog Neurobiol 19: 19-62
7. Facchinetti F, Petraglia F, Cicero S, Nappi G, Valentini M, Genazzani AR (1987) No gradient exists between lumbar and ventricular cerebrospinal fluid β-endorphin. Neurosci Lett 77: 349-352
8. Haverstick DM, Rubenstein A, Bannon MJ (1989) Striatal tachykinin gene expression regulated by interaction of D-1 and D-2 dopamine receptors. J Pharmacol Exp Ther 248: 858-862
9. Jackisch R, Geppert M, Brenner AS, Illes P (1986) Presynaptic opioid receptors modulating acetylcholine release in the hippocampus of the rabbit. Naunyn Schmiedebergs Arch Pharmacol 332: 156-162
10. Jessell TM, Mudge AW, Leeman SE, Yaksh TL (1979) Release of substance P and somatostatin, in vivo, from primary afferent terminals in mammalian spinal cord [Abstract]. Soc Neurosci 5: 611
11. Joshi D, Miller MM, Seidah NG, Day R (1995) Age-related alternations in the expression of prohormone convertase messenger ribonucleic acid (mRNA) levels in hypothalamic proopiomelanocortin mRNA neurons in the female C57BL/6J mouse. Endocrinology 136: 2721-2729
12. Khachaturian H, Lewis M, Schafer M, Watson S (1985) Anatomy of the CNS opioid systems. Trends Neurosci 8: 111-119
13. Matsuishi T, Sakai T, Nagamitsu S, Komori H, Iwashita H, Kato H (1994) Decreased cerebrospinal fluid levels of β-endorphin in Japanese patients with Joseph disease. Ann Neurol 36: 441-443
14. Matsuishi T, Sakai T, Nagamitsu S, Shoji H, Ueda N, Kaneko S, Kano T, Iwashita H, Kato H (1996) Decreased cerebrospinal fluid levels of substance P in Machado-Joseph disease. J Neurol Svi 142: 107-110
15. Matsuishi T, Nagamitsu S, Yamashita Y, Murakami Y, Kimura A, Sakai T, Shoji H, Kato H (1998) Decreased cerebrospinal fluid levels of substance P in adult patients with Rett syndrome. Am Neurol (in press)
16. Nagamitsu S, Matsuishi T, Ohnishi A, Kato H (1997) Decreased cerebrospinal fluid levels of substance P in patients with congenital sensory neuropathy with anhidrosis. Neurology 48: 1133
17. Nagamitsu S, Matsuishi T, Komori H, Kisa T, Miyazaki M, Hashimoto T, Yamashita Y, Otaki E, Kato H (1997) CSF β-endorphin levels in patients with infantile Autism. J Autism Dev Disord 27: 155-163
18. Nutt JG, Mroz EA, Leeman SE, Williams AC, Engel WK, Chase TN (1980) Substance P in human cerebrospinal fluid: reductions in peripheral neuropathy and autonomic dysfunction. Neurology 30: 1280-1285
19. Sahley TL, Panksepp J (1987) Brain opioids and autism: an updated analysis of possible linkages. J Autism Dev Disord 17: 201-216
20. Wang ZP, Man SY, Tang F (1993) Age-related changes in the content of neuropeptides in rat brain and pituitary. Neurobiol Aging 14: 529-534